The invention refers to agriculture, in particular, to the devices for heating the greenhouses with solar and underground power. The device contains a solar water heater, a water tank for heat accumulation, a flash tank, connection pipe-lines, a pump mounted in one of the pipe-lines and a solar battery. The greenhouse inner part is connected to its basement by air ducts in which there are mounted ...

A mobile X-ray apparatus has a carriage provided with at least one pair of independently driven driving wheels and a motor. The carriage includes a driving handle, which comprises sidebars, attached to a rotation axis solidly fixed to the carriage, and a crossbar, which is connected to the sidebars in an articulated manner to allow the turning movement of the sidebars about the said axis independe...

PCT No. PCT/EP95/01207 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 31, 1995 PCT Pub. No. WO95/28430 PCT Pub. Date Oct. 26, 1995Mixtures leading to hard polyurethane foamed materials, which mixtures are preferably present in a pressure vessel, contain a) prepolymers containing isocyanate groups, obtainable by the reaction of polyisocyanates containing isocyanurate grou...

PCT No. PCT/EP94/01652 Sec. 371 Date Dec. 4, 1995 Sec. 102(e) Date Dec. 4, 1995 PCT Filed May 24, 1994 PCT Pub. No. WO94/27599 PCT Pub. Date Dec. 8, 1994The invention relates to a pharmaceutical composition for rectal administration which comprises 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)- methyl]-4H-carbazol-4-one in the form of its free base or a pharmaceutically acceptable sol...

The present invention relates to a system including a mobile switching center, a base station communicating with the mobile switching center, a mobile station including a radio transmitter and a radio receiver for setting up a connection to the base station via the base station, an object including an identification mechanism, and a data processing device in which data relating to said object is m...

Methods and apparatus are provided that implement digital signing and/or encryption for the electronic transmission, storage, and retrieval of authenticated documents and that enable the establishment of the identity of the originator of an electronic document and of the integrity of the information contained in such a document. Together these provide irrevocable proof of authenticity of the docum...

8a-Azalides are useful in the treatment and prevention of bacterial respiratory and enteric infections in livestock animals, particularly in cattle and swine.

The process of the invention characterized in that to 100 parts by weight of a silicate powder having 2000-8000 m2/g specific surface, 1-10 parts by weight of gas-forming material with particle size of 10-100 mum and 0.5-15 parts by weight of montmorillonite, 0.5-2 parts by weight of alkali hydrogen phosphate or alkali dihydrogen phosphate or a mixture of alkali metal phosphate and sodium silicate...

The invention relates to a method for denitrifying waste waters in a clarification plant, comprising at least one preliminary clarification tank (2) with an inlet (1), at least one biological clarification stage (6) and at least one final clarification tank (8). The inventive method is characterized in that the nitrified waste water (9) contained in the final clarification tank (8) is recycled wit...

Chemical conjugates which comprise oligopeptides, having amino acid sequences that are selectively proteolytically cleaved by free prostate specific antigen (PSA) and known cytotoxic agents are disclosed. The conjugates of the invention are characterized by attachment of the cleavable oligopeptide to the oxygen atom at the 4-position on a vinca drug that has be desacetylated. Such conjugates are u...

This invention relates to a novel method for the chemical preparation of epirubicin or acid addition salts thereof, in particular the HCl salt, from daunorubicin. This process avoids the disadvantages of the prior art. First daunorubicin is methanolized to obtain daunomycinone and daunosamine methyl ether in very high yields. Daunomycinone is converted to 14-acetoxy daunomycinone by bromination an...

Lipopolyamines useful for the transfection of nucleic acid and methods of preparation thereof are disclosed. The lipopolyamines are of general formula I, in which R4 comprises at least one C10-C22 aliphatic radical.

There are provided certain 13-alkyl-23-imino and 13-halo-23-imino-LL-F28249 compounds which are useful for controlling endo- and ectoparasites, insects, acarids and nematodes.

The present invention relates to the new 15-membered ketoazalides from the class of 6-O-methyl-8a-aza-8a-homo-and 6-O-methyl-9a-aza-9a-homoerythromycin A with the general formula (I) wherein A represents NH group and B at the same time represents C=O group, or A represents C=O group and B at the same time represents NH group, R1 represents OH group, L-cladinosyl group of the formula (II) or togeth...

An improved process for the preparation of the antiparasitic compound 25-cyclohexyl-22,23-dihydro-5-hydroxyiminoavermectin B1 monosaccharide from doramectine and intermediates therefor and crystalline solvates thereof.

A compound of formula (I) which is an agonist at the adenosine A1 receptor wherein R2 represents C1-3alkyl, halogen or hydrogen; R3 represents a fluorinated straight or branched alkyl group of 1-6 carbon atoms and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof. These compounds are agonists at the adenosine A1 receptor.

A compound of formula (I) wherein R2 represents C1-3 alkyl, halogen or hydrogen; R3 represents a fluorinated straight or branched alkyl group of 1-6 carbon atoms; and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof. These compounds are agonists of the Adenosine A1 receptor.

There are provided according to the invention, novel compounds of formula (I) wherein R<1>, R<2 >and R<3 >are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory disease.

There are disclosed according to the invention, compounds of formula (I) wherein R1, R2 and R3 are defined in the specification. Additionally, processes of preparing the compounds of formula (I), formulations containing same, and the administration of said compounds or formulations thereof in the treatment of inflammatory diseases are also disclosed.

A liquid hydrocarbon composition, containing paraffinic hydrocarbon components in which the extent of branching, as measured by the percentage of methyl hydrogens (BI), and the proximity of branching, as measured by the percentage of recurring methylene carbons which are four or more carbons removed from an end group or branch (CH2>4), are such that: (a) BI - 0.5(CH2>4)>15; and (b) BI + 0.85(CH2>4...